Osprey Acquisition III

Where it stands

Searching · next dated event 2 July 2028

Outside date — not a date on which you can claim cash.

Merging with

No target announced — still searching.

Industry

AI/Tech

What it set out to buy: AI/Tech

Deal value

not stated in the filings we hold

Price vs cash floor

$9.84 vs $10.00

$0.16 below the last filed cash held for you; 2.3% below cash against our estimated ~$10.07

Cash left in trust

not yet extracted into a snapshot — the filings below may state it

IPO

1 July 2026

$261M raised · 100.0% of each $10 unit into trust

Headquarters

1845 WALNUT STREET, PHILADELPHIA, PA, 19103

registered in the Cayman Islands

Lead underwriter

Cantor Fitzgerald & Co.

Key officers

Kupfer Jeffrey F (Director) · Clifford Jeffrey (Director) · Elliott Thomas C (Chief Financial Officer)

Listed securities

OSPR common · OSPR common $9.84 · OSPRU unit $9.99

1. No dated redemption election is on file for this name. That is an absence in the record, not proof that the right has gone — but it does mean this page cannot tell you a day to act by.
2. Cash held in trust is $10.00 per share as last filed. That is the figure a redemption pays out at, plus whatever interest the trust earns between the filing and the window.
3. The charter runs to a date no filing we hold states; from the IPO date and the charter term we estimate 2 July 2028. Whenever it falls, if no deal closes by then the trust is returned to holders — a floor of a different kind: it pays out, but you do not choose when, and this one you should read out of the prospectus yourself.

1. 1 July 2026IPOpassed

   $261M raised into trust

2. 2 July 2028Outside date0001213900-26-088369

• 10-Q12 August 20260001213900-26-088369

  This is the first filing after the company became public, establishing the baseline trust value per share at $10.00 and a 24-month deadline of July 2, 2028. The document confirms standard SPAC structure with no unusual terms. The sponsor's promissory note was repaid, eliminating pre-IPO related-party debt.

• 8-K9 July 20260001213900-26-076742

  This filing finalizes the company's post-IPO capital structure and activates its operational timeline. The $300,150,000 trust deposit establishes the baseline for shareholder redemptions, with public shareholders entitled to redeem shares at a pro-rata portion of the trust account calculated two business days prior to a business combination or liquidation. The document sets a 24-month 'Completion Window' (ending July 2, 2028) to effect a business combination, subject to the condition that any target possess a fair market value of at least 80% of the net trust balance. It codifies warrant mechanics: 10,254,000 warrants are outstanding (priced at a fair value of $5,202,600 by management using a Monte Carlo model), exercisable at $11.50 per share, with a redemption trigger set at $18.00 per share. Furthermore, the Sponsor assumes indemnification liability to restore trust funds below $10.00 per share if diminished by third-party claims, while outlining that up to $2,500,000 in working capital loans may be converted into post-combination private placement units at $10.00 per unit at the lender's option.

• 8-K7 July 20260001213900-26-075986

  This filing establishes the trust account, the redemption mechanics, the 24-month deadline for a business combination, and the sponsor's lock-up periods. It is the starting point for tracking the SPAC's timeline and trust value. Investors should note that the trust per share is $10.00 and that the sponsor has a 25% stake that is locked up for one year after a business combination or earlier under certain conditions.

• 424B42 July 20260001213900-26-074446

  Investors gain the definitive operational and governance framework before capital deployment, clarifying precisely how the per-share trust balance computes upon business combination or extension, when the July 2, 2028 baseline expiration activates redemption or extension votes, and how nominal founder pricing combined with mandatory 25% anti-dilution conversion structurally prioritizes sponsor recovery over public shareholder par value protection.

• S-115 June 20260001213900-26-068811

  Establishes the terms of the SPAC IPO: 26.1M units at $10.00, trust per share $10.00, 24-month deadline to complete business combination, focus on energy sector. Provides details on sponsor economics, insider ownership, and redemption mechanics. Material for investors tracking new SPAC issuance.

• DRS6 March 20260001213900-26-024705

  These provisions establish the baseline dilution mechanics, redemption economics, and conflict-of-interest boundaries for the search phase. According to the filing, founder shares will convert to maintain a 25% post-combination ownership ratio unless waived, which the document states will cause 'immediate and substantial dilution' to public shareholders. Management claims the company targets the energy sector, citing International Energy Agency estimates referenced in the prospectus of $3.3 trillion in global energy investment in 2025, U.S.

• 8-K18 August 20260001213900-26-091214

  What changed: Form 8-K Current Report and Exhibit 99.1 press release announcing the mechanical decoupling and separate listing of Osprey Acquisition Corp. III’s Class A ordinary shares and warrants from its initial public offering units. Commencing August 21, 2026, unit holders may elect to separately trade the Class A ordinary shares (trading symbol 'OSPR') and warrants (trading symbol 'OSPRW') underlying each initial offering unit. Each whole warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share. Units that remain consolidated will continue trading under 'OSPRU'. The filing contains no amendments to the redemption calendar, trust account administration, extension voting thresholds, or deSPAC transaction timeline; the registrant maintains its pre-announcement 'SEARCHING' status with the July 2, 2028 liquidation deadline unchanged. Why it matters: This is a standard procedural listing event that unlocks independent pricing, hedging, and liquidity for warrants prior to any business combination announcement, but it does not accelerate, dilute, or otherwise alter the cash-based redemption mechanics or the 2028 termination deadline. Beyond the listing change, the attached press release formalizes the sponsor’s executive composition and stated acquisition mandate. According to the company’s filing, David Heikkinen serves as Chief Executive Officer, Daniel C. Herz and Jonathan Z. Cohen as Co-Executive Chairmen of the Board of Directors, Edward E. Cohen as Vice-Chairman, Thomas C. Elliott as Chief Financial Officer, and Jeffrey F. Brotman as Chief Operating Officer and Chief Legal Officer. The press release further specifies that the management team’s primary focus will be to identify companies deploying 'disruptive technologies and next-generation infrastructure that modernize energy systems, enable AI-driven optimization, and support the resilient, sustainable backbone of global connectivity.' Corporate correspondence is directed to info@whitehawkenergy.com, and the filing includes standard forward-looking statements disclaimers attributing strategic assumptions to company management. Investors tracking deployment velocity should treat this as a governance and liquidity structural update rather than a transaction catalyst.

• 10-Q12 August 20260001213900-26-088369

  What changed: Quarterly report on Form 10-Q for the period ended June 30, 2026. First periodic report since IPO; SPAC had not completed an acquisition as of June 30, 2026. On July 2, 2026 (after quarter-end), Osprey closed its IPO of 30,015,000 units (including full over-allotment) at $10.00/unit, raising $300,150,000. Simultaneously, the sponsor and Cantor Fitzgerald purchased 747,000 private placement units ($7,470,000). Trust Account holds $300,150,000 ($10.00/share). Pre-IPO, the company had only $22,607 cash and a $495,412 working capital deficit. The sponsor had loaned $175,000 which was repaid at IPO closing. Founder shares subject to forfeiture (1,305,000) were no longer subject to forfeiture after over-allotment exercise. No target identified; the company will have 24 months from July 2, 2026 to complete a business combination. Why it matters: This is the first filing after the company became public, establishing the baseline trust value per share at $10.00 and a 24-month deadline of July 2, 2028. The document confirms standard SPAC structure with no unusual terms. The sponsor's promissory note was repaid, eliminating pre-IPO related-party debt.

• 8-K9 July 20260001213900-26-076742

  What changed: Form 8-K reporting the consummation of the Initial Public Offering (IPO) and simultaneous private placement transaction. According to the filing, on July 2, 2026, Osprey Acquisition Corp. III closed its IPO by selling 30,015,000 Units at $10.00 per Unit, generating $300,150,000 in gross proceeds, which included the full exercise of a 3,915,000 Unit over-allotment option. Simultaneously, the company executed a private placement of 747,000 Private Placement Units at $10.00 per Unit for $7,470,000 in gross proceeds; Osprey Acquisition Sponsor III, LLC purchased 486,000 Units and Cantor Fitzgerald & Co. purchased 261,000 Units. The registration statement discloses that $300,150,000 was deposited into a U.S.-based trust account managed by Continental Stock Transfer & Trust Company. Total transaction costs totaled $18,575,142, broken down into a $5,220,000 cash underwriting fee, a $12,789,000 deferred underwriting fee, and $566,142 in other offering costs. As of July 2, 2026, the company held $1,416,915 in operating cash and prepaid $175,000 of an unsecured promissory note from the Sponsor. The filing also details ongoing administrative obligations, including $30,000 monthly payments to a sponsor affiliate and up to $12,500 monthly to the Chief Financial Officer, alongside the issuance of 10,254,000 founder shares that are no longer subject to forfeiture following the over-allotment exercise. Why it matters: This filing finalizes the company's post-IPO capital structure and activates its operational timeline. The $300,150,000 trust deposit establishes the baseline for shareholder redemptions, with public shareholders entitled to redeem shares at a pro-rata portion of the trust account calculated two business days prior to a business combination or liquidation. The document sets a 24-month 'Completion Window' (ending July 2, 2028) to effect a business combination, subject to the condition that any target possess a fair market value of at least 80% of the net trust balance. It codifies warrant mechanics: 10,254,000 warrants are outstanding (priced at a fair value of $5,202,600 by management using a Monte Carlo model), exercisable at $11.50 per share, with a redemption trigger set at $18.00 per share. Furthermore, the Sponsor assumes indemnification liability to restore trust funds below $10.00 per share if diminished by third-party claims, while outlining that up to $2,500,000 in working capital loans may be converted into post-combination private placement units at $10.00 per unit at the lender's option.

• SCHEDULE 13G9 July 20260001193125-26-299343

  What changed: A routine compliance exhibit: a Joint Filing Agreement (Exhibit A) submitted alongside a Schedule 13G beneficial ownership report. Linden Capital L.P., Linden GP LLC, Linden Advisors LP, and Siu Min Wong have formally agreed, through Saul Ahn’s signature on July 8, 2026, to submit their July 7, 2026 Schedule 13G statements jointly on behalf of each party under Rule 13d-1(k). This administrative coordination does not modify the issuer’s redemption mechanics, trust account status, extension triggers, or merger execution timeline. No changes to the July 2, 2028 business combination deadline or shareholder redemption rights are disclosed, invoked, or implied by the filing. Why it matters: The instrument attests solely to a shared reporting structure among the listed affiliates and individual holder. It contains zero operational disclosures, customer references, revenue data, market sizing, strategic directives, technology commitments, partnership arrangements, litigation alerts, or sponsor conduct evaluations. The only external factual anchors are the statutory reference to the Securities Exchange Act of 1934, a June 10, 2019 Power of Attorney, and a citation to a June 19, 2019 filing regarding Haymaker Acquisition Corp II. Because it presents no numerical holdings, cash position updates, target pipeline details, or governance shifts, it delivers no actionable intelligence for investors monitoring SPAC progression, trust solvency, or deal velocity.

• SCHEDULE 13G7 July 20260000912282-26-000921

  What changed: A Joint Filing Agreement (Exhibit 99.1) attached to a Schedule 13G beneficial ownership report. This exhibit contains no changes to Osprey Acquisition III’s redemption calendar, trust account mechanics, extension provisions, business combination timeline, or sponsor governance. MMCAP International Inc. SPC and MM Asset Management Inc. formally acknowledge that they will submit future Schedule 13G amendments jointly without drafting additional agreements, and each assumes independent responsibility for the completeness and accuracy of its own disclosures. The parties explicitly state they bear no liability for the other’s information unless they know or have reason to believe that information is inaccurate. Because this is only the joint-filing appendix, no share quantities, ownership percentages, purchase prices, or redemptions are disclosed, leaving all SPAC operational parameters unchanged. Why it matters: The document matters primarily as a procedural compliance step: MMCAP International Inc. SPC and MM Asset Management Inc. have aligned their regulatory filings through signatures by Ulla Vestergaard (Director) and Hillel Meltz (President), dated July 2, 2026. For investors monitoring Osprey Acquisition III, this confirms coordinated reporting between two investment vehicles but reveals nothing about actual accumulated positions, source of funds, voting intentions, or engagement with the sponsor ahead of the 2028-07-02 deadline. Without the accompanying Schedule 13G body showing stake size or acquisition history, the filing delivers no actionable signal on capital deployment, redemption pressure, or managerial conduct. Until the main 13G surfaces or amends to quantify holdings, the agreement remains a routine administrative record with zero direct impact on trust distribution mechanics or deal progression.

At-risk capital: $3.9M — 386,000 private placement units, bought at the IPO and worthless if the company liquidates. This is what the sponsor itself loses if no deal closes. per the prospectus (424B4 0001213900-26-074446)